Simon J Hogg

11PUBLICATIONS
105CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHealth and ecological risk assessmentMolecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia.

Katherine Knorr, Jahan Rahman, Caroline Erickson

|Sep 22, 2022
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.

Matthew T Witkowski, Soobeom Lee, Eric Wang

|Sep 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction.

Kenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson

|Jul 29, 2022
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.

Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro

|May 06, 2022
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia.

Joan So, Alexander C Lewis, Lorey K Smith

|Mar 21, 2022
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.

Jessica M Salmon, Izabela Todorovski, Kym L Stanley

Pageof 2

Frequent Collaborators

4 joint publications

Ricky W Johnstone

3 joint publications

Omar Abdel-Wahab

2 joint publications

Daichi Inoue

2 joint publications

Justin Taylor